Searched for
BIOGEN INC
ET Exclusive | Sun Pharma set to acquire Organon for $12.5 bn, its biggest till dateUS company’s board meeting is happening this weekend to finalise decision; an announcement is imminent later tonight or by Monday. Mumbai H...- The next big market boom? Mizuho analysts say baby boomers’ spending, not AI, will be a silver tsunami, to unlock a $1 trillion opportunityMizuho Financial Group's US analysts highlight a huge $1 trillion opportunity in 'aging intelligence'. America's aging population, especial...
- Dr Reddy's Laboratories jumps into the fray for Biogen's biosimilarsDr Reddy's Laboratories (DRL) and Intas Pharmaceuticals, both Indian companies, are reportedly in the race to acquire the biosimilar produc...
- New Alzheimer drug 'lecanemab' by Eisai Co and Biogen shows positive results but......, read what study saysThe ‘Eisai’ and ‘Biogen’ drug slowed cognitive decline in study participants, but many experienced brain bleeds, swelling, or other side ef...
- US stock market: Dow Jones, Nasdaq end down sharply, hit by Apple and China worriesShares of the Cupertino, California tech giant lost 2.6% and weighed heavily on the benchmark S&P 500 index as worker unrest at the world's...
- Wall St losses limited as Amazon gains on upbeat Cyber MondayThe Dow Jones Industrial Average fell 71.1 points, or 0.21%, at the open to 34,275.91
- Nasdaq leads Wall Street lower after hawkish Fed commentsThe Dow Jones Industrial Average was down 7.84 points, or 0.02%, at 33,740.02
- Biogen halves price of Alzheimer's drug to $28,200Biogen's $56,000 per year treatment price for an average weight person was seen as a significant cost burden on Medicare, which covers more...
- Wall Street rises on J&J, big tech boostThe S&P 500 and Dow indexes tracked weekly declines of about 1 per cent, their first since the turn of October, as hot US inflation reading...
- Warren Buffett's Berkshire pares drug holdings, sheds Axalta, BiogenIn the second quarter, Berkshire said it exited a $180 million stake in Biogen Inc and reduced investments in Abbvie Inc, Bristol-Myers Squ...
- Nasdaq, S&P 500 scale new peaks as jobs recovery gains tractionData showed fewer weekly jobless claims pointed to a steady recovery in the labor market.
- Wall Street ekes out gains to close languid weekThe Nasdaq gained the most among the three major indexes, while the bellwether S&P 500 squeaked its way to a second straight record closing...
- Dow Jones flat as investors await US inflation dataInvestors remained on the fence ahead of key inflation data later this week.
- GSK, Vir Biotech to expand COVID-19 research partnership for other diseasesAs a part of the deal to research and develop monoclonal antibody treatments for influenza and other respiratory illnesses, GSK will make a...
- FDA panel reviews first new Alzheimer's drug in 2 decadesA panel of outside experts meets Friday to advise the Food and Drug Administration on aducanumab, a drug from Cambridge, Massachusetts-base...
- Glenmark Pharma gets USFDA nod to market drug for relapsing multiple sclerosisDrug major Glenmark Pharma said it has received final approval from the US health regulator for Dimethyl Fumarate delayed-release capsules,...
- Japanese shares snap 3-day losing streak as battered stocks bought backThe Nikkei share average rose 1.52 per cent to 19,429.44 after three straight sessions of losses.
- Warren Buffett’s Berkshire raises stake in Biogen, KrogerBuffett’s company has been trimming its stakes in some major lenders to try to avoid crossing a 10% ownership threshold that often draws re...
- Glenmark gets tentative nod from USFDA for generic multiple sclerosis treatment drugThese are generic version of Tecfidera Capsules, 120 mg and 240 mg, of Biogen Inc.
- Why pharma may not fear the latest drug-price probeAs uncomfortable as it will be for the drugmakers, it may not result in much lasting damage.
Load More
